Elodie Josset

1.1k total citations · 1 hit paper
7 papers, 810 citations indexed

About

Elodie Josset is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Elodie Josset has authored 7 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Epidemiology and 2 papers in Oncology. Recurrent topics in Elodie Josset's work include Autophagy in Disease and Therapy (3 papers), CRISPR and Genetic Engineering (2 papers) and PARP inhibition in cancer therapy (2 papers). Elodie Josset is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), CRISPR and Genetic Engineering (2 papers) and PARP inhibition in cancer therapy (2 papers). Elodie Josset collaborates with scholars based in France, Belgium and South Africa. Elodie Josset's co-authors include G. Noël, Hélène Burckel, D. Antoni, Pierre Bischoff, Francis J. Dumont, Jean‐Marc Denis, John Gueulette, Didier Mutter, Stéphane Meunier and Frédéric Taran and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Oncology and Oncology Reports.

In The Last Decade

Elodie Josset

7 papers receiving 802 citations

Hit Papers

Three-Dimensional Cell Culture: A Breakthrough in Vivo 2015 2026 2018 2022 2015 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elodie Josset France 6 444 267 170 105 103 7 810
Caleb Jensen United States 5 639 1.4× 362 1.4× 309 1.8× 116 1.1× 131 1.3× 5 1.2k
Siyoung Choi United States 17 389 0.9× 439 1.6× 260 1.5× 179 1.7× 142 1.4× 29 1.2k
Verena M.C. Quent Australia 11 254 0.6× 146 0.5× 177 1.0× 94 0.9× 118 1.1× 13 636
Hélène Burckel France 10 464 1.0× 369 1.4× 319 1.9× 115 1.1× 121 1.2× 26 1.1k
Tongmeng Jiang China 18 274 0.6× 263 1.0× 76 0.4× 125 1.2× 117 1.1× 28 850
R. Michael Gower United States 16 223 0.5× 324 1.2× 141 0.8× 112 1.1× 245 2.4× 24 1.2k
Xintao Zhang China 18 278 0.6× 383 1.4× 93 0.5× 111 1.1× 145 1.4× 60 1.0k
Matthew Ibbs Poland 6 586 1.3× 376 1.4× 370 2.2× 110 1.0× 92 0.9× 11 1.2k
Gowri Manohari Balachander India 8 380 0.9× 231 0.9× 281 1.7× 57 0.5× 121 1.2× 18 776

Countries citing papers authored by Elodie Josset

Since Specialization
Citations

This map shows the geographic impact of Elodie Josset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elodie Josset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elodie Josset more than expected).

Fields of papers citing papers by Elodie Josset

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elodie Josset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elodie Josset. The network helps show where Elodie Josset may publish in the future.

Co-authorship network of co-authors of Elodie Josset

This figure shows the co-authorship network connecting the top 25 collaborators of Elodie Josset. A scholar is included among the top collaborators of Elodie Josset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elodie Josset. Elodie Josset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Antoni, D., Hélène Burckel, Elodie Josset, & G. Noël. (2015). Three-Dimensional Cell Culture: A Breakthrough in Vivo. International Journal of Molecular Sciences. 16(3). 5517–5527. 723 indexed citations breakdown →
2.
Antoni, D., Hélène Burckel, Elodie Josset, G. Noël, & F. Mornex. (2014). Radiobiologie des doses ablatives en radiothérapie stéréotaxique : mise au point des données récentes. Cancer/Radiothérapie. 18(4). 264–269. 5 indexed citations
3.
Burckel, Hélène, Elodie Josset, Jean‐Marc Denis, et al.. (2014). Combination of the mTOR inhibitor RAD001 with temozolomide and radiation effectively inhibits the growth of glioblastoma cells in culture. Oncology Reports. 33(1). 471–477. 6 indexed citations
4.
Josset, Elodie, Hélène Burckel, G. Noël, & Pierre Bischoff. (2013). The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line.. PubMed. 33(5). 1845–51. 28 indexed citations
5.
Bischoff, Pierre, Elodie Josset, & Francis J. Dumont. (2012). Novel pharmacological modulators of autophagy and therapeutic prospects. Expert Opinion on Therapeutic Patents. 22(9). 1053–1079. 14 indexed citations
6.
Josset, Elodie, Jean‐Marc Denis, John Gueulette, et al.. (2012). The mTOR inhibitor RAD001 augments radiation-induced growth inhibition in a hepatocellular carcinoma cell line by increasing autophagy. International Journal of Oncology. 41(4). 1381–1386. 26 indexed citations
7.
Josset, Elodie, Sami Benzina, Brice Nadal, et al.. (2011). Evaluation of the Radioprotective Potential of the Polyphenol Norbadione A. Letters in Drug Design & Discovery. 9(1). 48–53. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026